INOVIS Intelligent Competitor Strategies  CONTACT US
view Insights Insights view videos Videos view webinars Webinars view events Events
INOVIS Competitive Intelligence for Life Sciences / Pharma / Biotech / eHealth Life Sciences INOVIS Competitive Intelligence for Digital Health / Biotech / eHealth Digital HealthINOVIS Competitive Intelligence for Tech / Telecom / Cloudware Internet Tech
INOVIS' CI SERVICES Competitive / Competitor Investigations Competitor Investigations Competitive / Competitor Tracking Analysis Tracking & Analysis Medical Literature Monitoring Medical Literature IntelCompetitive Intelligence Security and Protection Security & Protection Competitive / Competitor Consulting and Training Workshops Consulting & Facilitation Competitive Intelligence Diagnostic and Prediction Tools INO-house Tools ®
WHY INOVIS? Competitive Intelligence / CI Specialists Our Company Competitive Intelligence / CI Analysts Our People recommended CI specialists Our Clients competitive intelligence CI research and analytics Careers
☰

INOVIS  PHARMA

-

Specialized primary competitive intelligence and strategic analysis & planning for the Life Sciences industry

-
INOVIS: Specialized Primary Intelligence and Strategic Consulting for Life Sciences / Biotech / Pharmaceuticals and Digital Health

Pharmaceuticals, biotechnology, medical devices, diagnostics, genomics, CROs and managed care companies have relied on our primary intelligence and strategic analysis services since 1992

Our Competitive Intelligence service expertise includes Branded, Gx, Biosimilar, telehealth/m-health/e-health (learn more about our Digital Health CI proficiencies+).

conference icon meet the team at conferences & symposia ⟩

Baljit Singh PhD, INOVIS Managing Director and Partner, Life Sciences Group
VIEW 2m VIDEOlearn more

THOUGHT
PARTNERING

Baljit shares how INOVIS supports decision-making and ultimately enables us to be a thought partner

INOVIS Life Sciences Group: Competitive Insight Series
VIEW FULL INTERVIEWlearn more

SOFTWARE AS A
MEDICAL DEVICElearn more

How will the Life Sciences integrate software as a medical device? Neha Gupta, Global Digital Product - Ipsen,  joined us to share expertise and insight on how this will dramatically impact the industry as a whole.

Late Life Cycle Management : Gx and Bx considerations in 2020
VIEW 1m VIDEOlearn more

LLCM Strategies

Late Life Cycle Management : Generic and Biosimilar considerations in 2020 ... and beyond

in-depth coverage

– clinical– regulatory
– commercial– manufacturing
– development– diagnostics
– market access. . . and more

Regulatory Intelligence

core specialty areas

Over the past 30 years we have conducted research across most core specialty areas, including:

  • Cardiology
  • Oncology
  • Neurology/CNS
  • Autoimmune Diseases
  • Vaccines
  • Generics
  • Biosimilars
  • Rx-to-OTC
  • Pain Management
  • Diabetes/Metabolism
  • Respiratory
  • Infectious Diseases
  • Urology
  • Endocrinology
thank you for your interest in INOVIS Competitor Intelligence and Strategy

EU +41.41.455.2522

US 1.650.298.8555

email INOVIS info@inovis.global

Follow INOVIS on LinkedIn find us on LinkedIn

sitemap site map

Copyright © 1992 - 2024 INOVIS